UNSPSC 41181920: Colon cancer nat tests

In this classification, a Colon cancer nat tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Colon cancer nat based tumors.

UNSPSC 41181920 Colon cancer nat tests (Commodity) does not map cleanly to the state and local procurement activity tagged under this code. The recent opportunities posted under this code span laboratory testing services, equipment repair and maintenance, spectrophotometer procurement, transformer oil analysis, landscape engineering, water reclamation system support, electric meter testing boards, water treatment plant well construction, fatigue testing equipment, and lock-in amplifiers — none of which align with colorectal cancer screening or diagnostic testing. The code appears to be a mislabeling artifact in state and local procurement systems, with agencies and platforms applying it to unrelated laboratory and technical service procurements. State and local governments do solicit laboratory testing and inspection services across health departments, public health labs, utilities, transportation authorities, and municipal service divisions, but these opportunities are not meaningfully characterized by the nominal scope of UNSPSC 41181920.

The recent opportunities reflect fragmented demand across geographies and issuing bodies. Marion County, Oregon posted an ITB for laboratory testing services and phlebotomy for Adults in Custody (due July 24, 2026); Texas Department of State Health Services sought laboratory equipment repair and maintenance for the South Texas Laboratory in Harlingen under IFB HHS0017421 (due July 6, 2026); the City of Tampa issued an RFQ for a Heck DR4900 Spectrophotometer replacement (due June 12, 2026); Lubbock Power & Light requested proposals for insulating oil testing laboratory services (due July 22, 2026); and Broward County Transportation Department solicited ChargePoint DC charger repair and maintenance services (due May 5, 2026). The code shows activity across Oregon, Texas, Florida, and multiple utility and county jurisdictions, but the diversity of actual work being procured—from phlebotomy to equipment maintenance to spectrophotometry—suggests the code's assignment is inconsistent or erroneous. No recent opportunities for colorectal cancer screening tests or related diagnostics appear in the source. Firms evaluating this code should verify issuing bodies' actual procurement intent before pursuit, as the nominal code scope does not predict the work that will be solicited.